The 1st MobiliTraIN press release is out!
Read our first press release which addresses why we need IM-HRMS, what challenges MobiliTraIN tackles and how the project will create impact through innovation.
THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
MobiliTraIN is a project set out to unlock the full potential of ion mobility-high resolution mass spectrometry (IM-HRMS), the next-generation analytical platform in research and industry. Running over four years, MobiliTraIN brings together a 22-partner large multidisciplinary consortium consisting of academia, instrumentation companies, regulatory agencies, a pharmaceutical industry leader, and several SMEs. The network will train 13 Doctoral Candidates to bring new fundamental understanding of IM-HRMS, provide reference materials and guidelines for standardisation, develop state-of-the-art methods for a variety of IM-HRMS applications and lay the foundations for its adoption in industry.
Read our first press release which addresses why we need IM-HRMS, what challenges MobiliTraIN tackles and how the project will create impact through innovation.
Project starting date set for February 2024, with the recruitment for 13 available PhD positions to start shortly!
MobiliTraIN receives 2.7 million euros from the Marie Sklodowska Curie Actions.